It looks like you're using an ad blocker.

To enjoy our content, please include The Japan Times on your ad-blocker's list of approved sites.

Thank you for supporting our journalism.

  • HOME DELIVERY |
  • SUBSCRIBE |
  • Login
  • My Account
TODAY'S PRINT EDITION

The Japan Times The Japan Times

pharmaceuticals

  • Login
  • SUBSCRIBE
  • My Account
  • HOME DELIVERY ≫
  • (FREE ARTICLE)
  • MENU
  • Search
  • News
  • Opinion
  • Life
  • Community
  • Culture
  • Sports
  • City Guide
  • Support
  • Search
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
When it comes to a restart of global travel, all vaccines are not equal

World Apr 26, 2021

When it comes to a restart of global travel, all vaccines are not equal

A patchwork of approvals across the world is laying the groundwork for a global vaccine bifurcation, where the shot you get could determine which countries you can enter and work in.

U.S. ends Johnson & Johnson COVID-19 vaccine pause, says shots to resume immediately

World Apr 24, 2021

U.S. ends Johnson & Johnson COVID-19 vaccine pause, says shots to resume immediately

Officials found just 15 cases among the 8 million shots given that had experienced the syndrome involving severe blood clots and low platelets as a result of the vaccine.

How South Korea stepped up specialty syringe production for COVID-19 vaccines

Asia Pacific Apr 23, 2021

How South Korea stepped up specialty syringe production for COVID-19 vaccines

by Sangmi Cha

South Korea's relative abundance of low dead space syringes has helped it give 3.4% of its population at least one dose of a coronavirus vaccine, compared with 1.1% in Japan.

U.S. weighs global vaccine intellectual property waiver opposed by drugmakers

World Apr 22, 2021

U.S. weighs global vaccine intellectual property waiver opposed by drugmakers

by Eric Martin and Susan Decker

The European Union, U.K., Japan, Switzerland, Brazil and Norway are also among territories resisting the measure currently before the WTO.

How the WHO's push for global vaccines needled Europe

World Apr 21, 2021

How the WHO's push for global vaccines needled Europe

by Francesco Guarascio and John Chalmers

The EU's ambivalence stems partly from short supplies and a slack start to the COVAX program, but also from concerns that the EU's efforts will go unnoticed in a vaccine diplomacy war.

COVID-19 survivors may need just one shot of a two-dose vaccine, studies show

World Apr 18, 2021

COVID-19 survivors may need just one shot of a two-dose vaccine, studies show

by Carey Goldberg

The issue has become all the more urgent since safety concerns have been raised about vaccines from Johnson & Johnson and AstraZeneca.

Why the vaccine safety numbers are still fuzzy

World / Science & Health Apr 17, 2021

Why the vaccine safety numbers are still fuzzy

by Margot Sanger-Katz and Alicia Parlapiano

If there is a connection between the Johnson & Johnson vaccine and a rare clotting syndrome, new cases are likely to emerge now that the word is out.

Suga to hold phone talks with Pfizer executive

National Apr 16, 2021

Suga to hold phone talks with Pfizer executive

Some Japanese government sources said Suga is arranging to hold talks with Pfizer CEO Albert Bourla via telephone on Friday or Saturday Japan time.

How China fell behind after passing up a vaccine opportunity

Asia Pacific Apr 15, 2021

How China fell behind after passing up a vaccine opportunity

by Bruce Einhorn

In the early stages of the pandemic, China and other Asian nations failed to jump on mRNA tech, which has become the breakout star of the COVID-19 era.

Vaccine blood-clot side effect puts focus on immune reaction

World / Science & Health Apr 14, 2021

Vaccine blood-clot side effect puts focus on immune reaction

by John Lauerman and Robert Langreth

Health officials are exploring whether and how an immune reaction may occur in people who have received vaccines made by AstraZeneca and Johnson & Johnson.

U.S. calls for pause on Johnson & Johnson vaccine after clotting cases

World Apr 13, 2021

U.S. calls for pause on Johnson & Johnson vaccine after clotting cases

by Noah Weiland, Sharon Lafraniere and Carl Zimmer

The concerns about the shot mirror those about AstraZeneca’s, which European regulators began investigating last month after some recipients developed blood clots.

Asian nations scale back AstraZeneca rollout amid safety woes

Asia Pacific Apr 12, 2021

Asian nations scale back AstraZeneca rollout amid safety woes

by Michelle Fay Cortez

The moves may delay protection for the region amid concerns that the shot could trigger a rare and potentially deadly blood clotting condition.

« 1 … 16 17 18 … 42 »
  • WHAT’S TRENDING
  • EDITORS’ PICKS
  • Nadeshiko Japan downs Costa Rica to move into knockout stage

    Thumbnail image
  • AI is rewriting the rules of $200 billion games industry

    Thumbnail image
  • Indonesia rides EV rush to domestic IPO boom

    Thumbnail image
  • 'Japan's Anatolia' becomes a home away from home for Kurds and Turks

    Thumbnail image
  • From 'Young General' to 'Supreme Leader': The evolution of Kim Jong Un

    Thumbnail image

PODCAST

  • DEEP DIVE

    A tale of two Fujis: Bullet climbs, crowds and Lizzo

Return to The Japan Times top page
JT Digital Archives The Japan Times Alpha JT Bookclub The Japan Times Jobs Education in Japan
  • SUBSCRIBE
  • NEWSLETTERS
  • ePaper Edition
  • News
    • National
    • World
    • Business
    • Asia Pacific
    • Reference
    • Columns
    • Multimedia
  • Opinion
    • Editorials
    • Commentary
    • Cartoons
  • Life
    • Travel
    • Digital
    • Food & Drink
    • Environment
    • Style & Design
    • Language
    • Lifestyle
    • People
    • Columns
    • Multimedia
  • Community
    • Voices
    • Issues
    • Our Lives
    • Event listings
    • How-tos
    • Columns
  • Culture
    • Film
    • Music
    • Art
    • Stage
    • Events
    • Festivals
    • Books
    • TV
    • Columns
    • Multimedia
  • Sports
    • Rugby
    • Baseball
    • Soccer
    • Basketball
    • Sumo
    • Figure Skating
    • Tennis
    • More Sports
    • Columns
    • Multimedia
  • City Guide
    • Restaurants
    • Places
  • Support
    • About us
    • Faqs
  • About us
  • Contact us
  • Work with us
  • Privacy Policy
  • Link policy
  • Republishing
  • FAQs
  • Announcements
  • Press
  • Sitemap
  • Advertise

The Japan Times LTD. All rights reserved.

The Japan Times